Montreal, October 20, 2016 – O3D has benefited from a $ 125,000 investment through the partnership between Desjardins – Innovatech and the Health Technology Campus (CTS) that supports companies in the field of medical technology. The company will accelerate the design and manufacture of orthopedic devices thanks to the opportunities offered by new technologies.
For Eric Moreau, president of O3D, “the collaboration with the CTS allows us to accelerate our development projects. The flexible support structure allows you to quickly take up the challenges a start-up company can experience. ”
“O3D is a modern company that adapts technological change to the service of medical innovation. O3D’s ability to innovate in the accessibility and quality of diagnostics makes it a solid undertaking, said Guillaume Hervé, Chairman of CTS. It is in this direction that the CTS program with Desjardins – Innovatech wants to continue to invest and increase the development of innovation in medical technologies. It is with conviction that the CTS will continue to support this dynamic so that O3D takes a new step in its development process. ”
O3D is the first company in Quebec to market orthopedic devices entirely designed by digital acquisition and 3D printing. Headed by Eric Moreau, O3D’s primary objective is to simplify the process of making orthotics, from clinical consultation to the manufacture of parts, to taking measurements and adapting orthotic models. The company integrates digital input using a digitizer using specialized hardware in a tablet. The goal is to design a series of orthopedic devices that can be adapted to the measurements captured by the digitizer. The manufacturing process based on 3D technology enables the design and manufacture of a variety of orthotics according to customer needs. The structure also makes it possible to test the products in real situations with real patients.
O3D wants to seize the opportunity and transform a sector by multiplying the types of materials with an evolution of the design and digitization tools. Thanks to the $ 125,000 granted, Desjardins – Innovatech, through the CTS program, accompanies the company in its transformation to take it one step further in order to gain new market shares.
O3D is a company offering a turnkey service to clinicians. A mobile application allows the orthotist to have continuous control over the process and quality. The company also supports manufacturing by producing customized devices within a standardized process using 3D printing to optimize the design of the devices. Production is fast and inexpensive.
CTS is an accelerator of companies in the field of medical technologies which offers them to develop faster and increases their chances of success. The goal of the CTS is to offer start-up companies a unique proposition with structured framework that allows them to focus on developing their technology, reaching market dynamics and gaining the visibility they need to start and develop internationally.
About Desjardins – Innovatech
Created in 2005, the Desjardins – Innovatech fund was created by the initiative of the Government of Québec and Capital régional et coopératif Desjardins. With more than $ 55 million invested in nearly 40 companies and funds, Desjardins – Innovatech’s main mission is to promote and support companies from Quebec, who involved in the development of technological innovation or Industrialists and the new generation of Quebec innovation entrepreneurs, with their capital financing. In order to fulfill its mission, the fund joins forces with other players in the technological field – specialized investment funds, entrepreneurs, financial angels, technological company’s accelerators – contributing to increase PME in terms of job creation and economic development.
For additional information (journalists only)
Romain Lortille Bruel
Director of Business Development
514-274-1001 or 514-808-9775
Desjardins – Innovatech
418-835-8444 or 1-866-835-8444, ext. 556 3163